Johnson & Johnson vaccine trial halted by participant’s illness
Johnson & Johnson has paused its COVID-19 vaccine study because one of its participants was taken ill. The 60,000-patient clinical trial met the criteria for a “pausing rule,” reported Stat News,
Read More

Recent Comments